Notably, more than half of the patients who tested BRAF V600E positive only through ddPCR presented later with sentinel lymph node metastases, suggesting that ddPCR is the most suitable methodology for detecting the low-frequency BRAF V600E-positive melanoma clones in patients’ tissues [91]. The gene discussed is BRAF; the disease is melanoma.